Terms: = Germ cell tumor AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Treatment
19 results:
1. Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma.
Sakunrangsit N; Khuisangeam N; Inthanachai T; Yodsurang V; Taechawattananant P; Suppipat K; Tawinwung S
Cancer Immunol Immunother; 2024 Apr; 73(6):98. PubMed ID: 38619641
[TBL] [Abstract] [Full Text] [Related]
2. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
3. IL-7R licenses a population of epigenetically poised memory CD8
Micevic G; Daniels A; Flem-Karlsen K; Park K; Talty R; McGeary M; Mirza H; Blackburn HN; Sefik E; Cheung JF; Hornick NI; Aizenbud L; Joshi NS; Kluger H; Iwasaki A; Bosenberg MW; Flavell RA
Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2304319120. PubMed ID: 37459511
[TBL] [Abstract] [Full Text] [Related]
4. Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure.
Qu R; Kluger Y; Yang J; Zhao J; Hafler DA; Krause DS; Bersenev A; Bosenberg M; Hurwitz M; Lucca L; Kluger HM
Mol Cancer; 2022 Dec; 21(1):219. PubMed ID: 36514045
[TBL] [Abstract] [Full Text] [Related]
5. Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
Khushalani NI; Vassallo M; Goldberg JD; Eroglu Z; Kim Y; Cao B; Ferguson R; Monson KR; Kirchhoff T; Amato CM; Burke P; Strange A; Monk E; Gibney GT; Kudchadkar R; Markowitz J; Brohl AS; Pavlick A; Richards A; Woods DM; Weber J
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36450385
[TBL] [Abstract] [Full Text] [Related]
6. Analyzing Prognostic Hub Genes in the Microenvironment of Cutaneous Melanoma by Computer Integrated Bioinformatics.
Li G; Zhang J; Liu Y; Cheng X; Sun K; Hong W; Sha K
Comput Intell Neurosci; 2022; 2022():4493347. PubMed ID: 35300397
[TBL] [Abstract] [Full Text] [Related]
7. Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis.
Zhang C; Dang D; Cong L; Sun H; Cong X
Cancer Med; 2021 Jul; 10(14):4710-4720. PubMed ID: 34159752
[TBL] [Abstract] [Full Text] [Related]
8. Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.
Novik AV; Protsenko SA; Baldueva IA; Berstein LM; Anisimov VN; Zhuk IN; Semenova AI; Latipova DK; Tkachenko EV; Semiglazova TY
Oncologist; 2021 May; 26(5):364-e734. PubMed ID: 33749049
[TBL] [Abstract] [Full Text] [Related]
9. Nivolumab and ipilimumab are associated with distinct immune landscape changes and response-associated immunophenotypes.
Woods DM; Laino AS; Winters A; Alexandre J; Freeman D; Rao V; Adavani SS; Weber JS; Chattopadhyay PK
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369447
[TBL] [Abstract] [Full Text] [Related]
10. An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.
Chen MH; Chou WC; Hsiao CF; Jiang SS; Tsai HJ; Liu YC; Hsu C; Shan YS; Hung YP; Hsich CH; Chiu CH; Liu TC; Cho SF; Liu TW; Chao Y
Oncologist; 2020 May; 25(5):e782-e788. PubMed ID: 31852810
[TBL] [Abstract] [Full Text] [Related]
11. Decline of programmed death-1-positive circulating T regulatory cells predicts more favourable clinical outcome of patients with melanoma under immune checkpoint blockade.
Gambichler T; Schröter U; Höxtermann S; Susok L; Stockfleth E; Becker JC
Br J Dermatol; 2020 May; 182(5):1214-1220. PubMed ID: 31361026
[TBL] [Abstract] [Full Text] [Related]
12. Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics.
Prah MA; Al-Gizawiy MM; Mueller WM; Cochran EJ; Hoffmann RG; Connelly JM; Schmainda KM
J Neurooncol; 2018 Jan; 136(1):13-21. PubMed ID: 28900832
[TBL] [Abstract] [Full Text] [Related]
13. Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.
Goods BA; Hernandez AL; Lowther DE; Lucca LE; Lerner BA; Gunel M; Raddassi K; Coric V; Hafler DA; Love JC
PLoS One; 2017; 12(9):e0181538. PubMed ID: 28880903
[TBL] [Abstract] [Full Text] [Related]
14. Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).
Gururangan S; Reap E; Schmittling R; Kocak M; Reynolds R; Grant G; Onar-Thomas A; Baxter P; Pollack IF; Phillips P; Boyett J; Fouladi M; Mitchell D
Cancer Immunol Immunother; 2017 Dec; 66(12):1589-1595. PubMed ID: 28825123
[TBL] [Abstract] [Full Text] [Related]
15. Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination.
Vence LM; Wang C; Pappu H; Anson RE; Patel TA; Miller P; Bassett R; Lizee G; Overwijk WW; Komanduri K; Benjamin C; Alvarado G; Patel SP; Kim K; Papadopoulos NE; Bedikian AY; Homsi J; Hwu WJ; Boyd R; Radvanyi L; Hwu P
J Immunother; 2013 May; 36(4):276-86. PubMed ID: 23603862
[TBL] [Abstract] [Full Text] [Related]
16. A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.
Ebert LM; MacRaild SE; Zanker D; Davis ID; Cebon J; Chen W
PLoS One; 2012; 7(10):e48424. PubMed ID: 23110239
[TBL] [Abstract] [Full Text] [Related]
17. Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients.
Fong B; Jin R; Wang X; Safaee M; Lisiero DN; Yang I; Li G; Liau LM; Prins RM
PLoS One; 2012; 7(4):e32614. PubMed ID: 22485134
[TBL] [Abstract] [Full Text] [Related]
18. Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2.
Bjoern J; Brimnes MK; Andersen MH; Thor Straten P; Svane IM
Scand J Immunol; 2011 Mar; 73(3):222-33. PubMed ID: 21204893
[TBL] [Abstract] [Full Text] [Related]
19. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.
Puusaari I; Damato B; Kivelä T
Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):522-33. PubMed ID: 17111148
[TBL] [Abstract] [Full Text] [Related]